Cas:2179-89-7 2-(1,3-diphenylimidazolidin-2-ylidene)-1,3-diphenylimidazolidine manufacturer & supplier

Chemical Name:2-(1,3-diphenylimidazolidin-2-ylidene)-1,3-diphenylimidazolidine

CAS.NO:2179-89-7

Synonyms:1,1′,3,3′-tetra-phenyl-2,2′-biimidazolidinylidene;1,1′,3,3′-Tetraphenyl-2,2′-biimidazolidinyliden

Molecular Formula:C₃₀H₂₈N₄

Molecular Weight:444.57000

HS Code:2933290090

Physical and Chemical Properties:

Melting point:284-286ºC (dec.)

Boiling point:554.2ºC at 760mmHg

Density:1.23g/cm3

Index of Refraction:1.685

PSA:12.96000

Exact Mass:444.23100

LogP:6.42660

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1,1′,3,3′-tetra-phenyl-2,2′-biimidazolidinylidene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,1′,3,3′-Tetraphenyl-2,2′-biimidazolidinyliden physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,1′,3,3′-tetra-phenyl-2,2′-biimidazolidinylidene Use and application,1,1′,3,3′-tetra-phenyl-2,2′-biimidazolidinylidene technical grade,usp/ep/jp grade.

Related News: In order to find answers to these questions, our staff in the development department set about conducting a series of experiments. 2-(1,3-diphenylimidazolidin-2-ylidene)-1,3-diphenylimidazolidine manufacturer A key publication in a preclinical model demonstrated rigosertib��s ability to block cellular signaling by targeting RAS effector pathways (Divakar, S.K., et al., 2016: ��A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling.�� Cell 165, 643). 2-(1,3-diphenylimidazolidin-2-ylidene)-1,3-diphenylimidazolidine supplier Chinese nationals coming from China and connecting through another foreign airport will be denied travel. Those with pre-clearance are exempted. 2-(1,3-diphenylimidazolidin-2-ylidene)-1,3-diphenylimidazolidine vendor A GSK spokesman said it was not yet clear by when ViiV would be able to address the FDA��s concerns. 2-(1,3-diphenylimidazolidin-2-ylidene)-1,3-diphenylimidazolidine factory A GSK spokesman said it was not yet clear by when ViiV would be able to address the FDA��s concerns.